首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1576926

傷口縫合設備的全球市場:洞察，競爭情形，市場預測:2030年

Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年10月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球傷口閉合裝置市場規模為148.2億美元。預計到 2030 年，該市場將達到 226.4 億美元，2024 年至 2030 年的預測期間複合年增長率為 7.40%。對傷口閉合裝置的需求主要是由於慢性和急性傷口發生率的增加而推動的。此外，外科手術數量的增加、產品發布的增加以及主要市場參與者的批准是在 2024-2030 年預測期內顯著推動整個傷口閉合設備市場的因素。

澳洲糖尿病足協會（DFA）提供的最新數據（2022年）顯示，在澳大利亞，每10萬人中就有30萬人面臨糖尿病足病（DFD）的風險，其中500萬人已經患有糖尿病足病。其中，12,500 人接受了與糖尿病相關的截肢手術，1,000 人目前因 DFD 住院。此外，IDF Atlas報告（2022年）提供的最新數據和統計顯示，在非洲國家，糖尿病足潰瘍（DFU）的發生率在10.0%至30.0%之間，下肢截肢（LLA）的盛行率在發病率為3.0%至35.0%。糖尿病足潰瘍是慢性傷口，通常需要專門的治療和先進的傷口閉合解決方案。隨著這些潰瘍盛行率的增加，對能夠有效管理和閉合這些傷口的產品的需求不斷增長。此外，與糖尿病相關的截肢通常需要傷口閉合裝置來進行初步傷口護理和持續護理。先進的傷口閉合產品有助於促進手術部位的管理和癒合，減少進一步併發症和再次手術的可能性。因此，傷口閉合裝置的市場需求預計在預測期內將會擴大。

此外，該公司還透過擴大傷口閉合設備的生產並獲得監管部門的批准來策略性地擴大其市場佔有率，以推動進一步成長。例如，2023 年 6 月，Sree Chitra Tirunal 醫學科技研究所 (SCTIMST) 獲得了中央藥品標準控制組織 (CDSCO) 的批准，名為 Cholederm 的先進傷口護理產品。 Cholederm 用於加速各種皮膚傷口的癒合，包括燒傷和糖尿病傷口。 Cholederm 預計將降低治療成本，並使先進的傷口護理變得更實惠。

然而，人們對微創手術的日益偏好和感染風險可能會抑制傷口閉合裝置的未來市場。

本報告提供全球傷口縫合設備市場相關調查，提供市場概要，以及各產品類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

Medtronic
3M
Johnson & Johnson
B. Braun Melsungen AG
Baxter
Smith & Nephew
Stryker
Chemence Medical, Inc.
Healthium Medtech
Meril Life Sciences Pvt. Ltd.
Futura Surgicare Pvt Ltd.
Advanced Medical Solutions Group plc.
Microcure (Suzhou) Medical Technology Co., Ltd.
CooperSurgical Inc.
Adhezion Biomedical
CENTENIAL SURGICAL SUTURE LTD
Cardinal Health
Dukal LLC
ORION SUTURES INDIA PVT LTD
Lotus Surgicals

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明和諮詢方式

簡介目錄圖表

Product Code: DIMDCL0149

Wound Closure Devices by Product Type (Sealants & Adhesives, Staplers, Sutures [Absorbable and Non-Absorbable], Hemostats, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic and acute wounds, increase in surgical procedure across the globe, and increase in product launches and approvals by the key market players.

The global wound closure devices market was valued at USD 14.82 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 22.64 billion by 2030. The demand for wound closure devices is primarily being boosted by the rising incidence of chronic and acute wounds. Additionally, increasing surgical procedures, and growing product launches and approvals by the key market players are some of the factors responsible for significantly boosting the overall market for wound closure devices during the forecast period from 2024 to 2030.

Wound Closure Devices Market Dynamics:

According to the latest data provided by the Diabetes Feet Australia (DFA) (2022), in Australia, 300,000 individuals are at risk of developing diabetic foot disease (DFD) per 100,000 population, with 50,000 already living with the condition. Of these, 12,500 people have undergone diabetes-related amputations, and 1,000 are currently hospitalized due to DFD. Additionally, as per the recent data and stats provided by IDF Atlas Report (2022), in African countries, the rates of diabetic foot ulcers (DFU) range from 10.0% to 30.0%, while the prevalence of lower limb amputations (LLA) varies between 3.0% and 35.0%. Diabetic foot ulcers are chronic wounds that often require specialized treatment and advanced wound closure solutions. As the prevalence of these ulcers rises, there is a growing demand for products that can effectively manage and close these wounds. Additionally, diabetic-related amputations often require wound closure devices for both the initial wound and ongoing care. Advanced wound closure products help manage surgical sites and promote healing, reducing the likelihood of further complications and repeat surgeries. Thus, the market demand for wound closure device is expected to escalate during the forecasted period.

According to the recent data provided by the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population. Additionally, Finland recorded 15,870 surgical procedures per 100,000 population in the same year. As the number of surgical procedures rises, whether due to a growing population, advancements in medical technology, or more surgeries being performed for various conditions, the need for wound closure devices correspondingly increases thereby escalating the overall market.

Additionally, companies are amplifying their production of wound closure devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in June 2023, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) received approval from the Central Drugs Standard Control Organization (CDSCO) for its advanced wound care product called Cholederm. It is used for faster healing of various skin wounds, including burns and diabetic wounds. Cholederm is expected to reduce treatment costs and make advanced wound care more affordable.

Thus, the factors mentioned above are likely to boost the market of wound closure devices during the forecasted period.

However, the rising preference of minimally invasive surgeries and risk of infection may hinder the future market of wound closure devices.

Wound Closure Devices Market Segment Analysis:

In the product type segment of wound closure devices market the sutures are expected to hold a significant share in 2023. Sutures play a significant role in boosting the overall market for wound closure devices due to their widespread use, versatility, and continuous innovation. Sutures are used in a variety of surgical procedures, from minor outpatient surgeries to major operations. Their versatility across different types of wounds and surgeries contributes to their high demand. Sutures are applicable in general surgery, orthopedic surgery, gynecological procedures, and more, broadening their market appeal. Additionally, the development of advanced materials, such as bioabsorbable sutures, antimicrobial-coated sutures, and high-strength synthetic fibers, has enhanced the performance and safety of sutures, driving their adoption. Furthermore, sutures are generally cost-effective compared to some other wound closure options. Their affordability makes them a preferred choice, especially in low-resource settings or where budget constraints are a concern. Moreover, sutures that are compatible with new and minimally invasive surgical techniques, such as laparoscopic surgery, drive their usage in modern medical practices. Sutures used in conjunction with other advanced surgical devices and technologies, such as robotic-assisted surgery, enhance their market presence.

Furthermore, growing recommendation by the government organizations for use of technologically advanced sutures is also a factor that will boost the market growth of sutures. For instance, recently in June 2021, Ethicon Plus sutures became the first-ever suture with antibacterial protection to be recommended for use in NHS by NICE Medical Technologies Guidance as it has been shown to reduce the risk of surgical site infections (SSIs) by nearly 30%.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global wound closure devices market during the forecast period.

North America is expected to dominate the overall wound closure devices market:

North America is expected to account for the highest proportion of the wound closure devices market in 2023, out of all regions. This can be ascribed to the increasing incidence of chronic and acute wound across the region, growing surgical procedures, and the presence of key market players engaged in merger, acquisition, product launch, and other market activities across the region, which will further escalate the market of wound closure devices during the forecast period.

As per the American Society for Biochemistry and Molecular Biology in the year 2021, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. The above mentioned source further stated that about 2.8 million people suffer from Traumatic Brain Injury (TBI) each year in the United States from which 2,80,000 people result in hospitalizations.

Additionally, as per the recent data provided by the World Bank Group, in 2021, approximately 6,928 surgical procedures were performed per 100,000 population in Canada.

As per the recent data provided by Centre for Disease Control and Prevention (2024), in 2021, 38.4 million people of all ages or 11.6% of the U.S. population had diabetes. Additionally, as per the same source, 80% of Lower-limb amputations (LLAs) are a result of complications from diabetes.

As the global prevalence of diabetes increases, the number of individuals experiencing diabetic wounds and requiring surgical interventions also rises. This leads to higher demand for wound closure devices tailored to managing diabetes-related complications. Furthermore, the rise in surgical procedures, including elective and emergency surgeries, increases the need for wound closure devices. This includes both minor procedures and major surgeries where effective wound closure is crucial thereby escalating the overall market of wound closure devices.

Additionally, the increasing number of product development activities in the region is further going to accelerate the growth of the wound closure devices market. For instance, in October 2023, DuPont announced the introduction of its new DuPont(TM) Liveo(TM) MG 7-9960 Soft Skin Adhesive. The higher-adhesion, low-cyclics silicone soft skin adhesive (SSA) was designed for advanced wound care dressings and for adhering medical devices to the skin for long wear time and gentle removal.

Therefore, the above-mentioned factors are expected to bolster the growth of the wound closure devices market in the North America during the forecast period.

Wound Closure Devices Market Key Players:

Some of the key market players operating in the wound closure devices market include Medtronic, 3M, Johnson & Johnson, B. Braun Melsungen AG, Baxter, Smith & Nephew, Stryker, Chemence Medical, Inc., Healthium Medtech, Meril Life Sciences Pvt. Ltd., Futura Surgicare Pvt Ltd. Advanced Medical Solutions Group plc, Microcure (Suzhou) Medical Technology Co., Ltd., CooperSurgical Inc, Adhezion Biomedical, CENTENIAL SURGICAL SUTURE LTD, Cardinal Health, Dukal LLC, ORION SUTURES INDIA PVT LTD, Lotus Surgicals, and others.

Recent Developmental Activities in the Wound Closure Devices Market:

In August 2023, Medela, Inc., announced that it had introduced a new innovative sterile dressing within its negative pressure wound therapy (NPWT) portfolio in September. The Invia(R) Integrated Dressing was indicated for all wound types, including closed surgical incisions, and could be used in both hospital and home settings for up to seven days.
In May 2022, Advanced Medical Solutions Group plc, a world leader in tissue-healing technologies, announced that it had received FDA 510(k) approval for LiquiBand(R) XL. This new device, designed to close longer wounds, included a surgical mesh for wound closure and LiquiBand(R) glue to strengthen the closure and prevent infection.

Key Takeaways From the Wound Closure Devices Market Report Study:

Market size analysis for current wound closure devices size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the wound closure devices market.
Various opportunities available for the other competitors in the wound closure devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current wound closure devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for wound closure devices market growth in the coming future?

Target Audience who can be Benefited From This Wound Closure Devices Market Report Study:

Wound closure devices product providers
Research organizations and consulting companies
Wound closure devices -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in wound closure devices
Various end-users who want to know more about the wound closure devices market and the latest technological developments in the wound closure devices market.

Frequently Asked Questions for the Wound Closure Devices Market:

1. What are wound closure devices?

Wound closure devices include sutures, staples, and specially designed mechanical devices that help to close wounds by manipulating the edges of the wound tissue more closely. Apart from these, sealants, strips, and adhesives are also used to close the wound.

2. What is the market for wound closure devices?

The global wound closure devices market was valued at USD 14.82 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 22.64 billion by 2030.

3. What are the drivers for the wound closure devices market?

The demand for wound closure device market is primarily being boosted by the rising incidence of chronic and acute wounds. Additionally, increasing surgical procedures, and growing product launches and approvals by key market are some of the factors responsible for significantly boosting the overall market for wound closure devices during the forecast period from 2024 to 2030.

4. Who are the key players operating in the wound closure devices market?

Some of the key market players operating in the Wound Closure Devices market include Medtronic, 3M, Johnson & Johnson, B. Braun Melsungen AG, Baxter, Smith & Nephew, Stryker, Chemence Medical, Inc., Healthium Medtech, Meril Life Sciences Pvt. Ltd., Futura Surgicare Pvt Ltd. Advanced Medical Solutions Group plc, Microcure (Suzhou) Medical Technology Co., Ltd., CooperSurgical Inc, Adhezion Biomedical, CENTENIAL SURGICAL SUTURE LTD, Cardinal Health, Dukal LLC, ORION SUTURES INDIA PVT LTD, Lotus Surgicals, and others.

5. Which region has the highest share in the wound closure devices market?

North America is expected to account for the highest proportion of the wound closure devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of chronic and acute wound across the region, increase in surgical procedure, increase government initiatives, and the presence of key market players engaged in merger, acquisition, product launch, and other market activities across the region are expected to escalate the market of wound closure devices during the forecast period.

1. Wound Closure Devices Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Wound Closure Devices Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Wound Closure Devices Market Key Factors Analysis

5.1. Wound Closure Devices Market Drivers
- 5.1.1. Rising prevalence of chronic and acute wounds
- 5.1.2. Increasing number of surgical procedure across the globe
- 5.1.3. Growing product launches and approvals by key market players across the globe
5.2. Wound Closure Devices Market Restraints and Challenges
- 5.2.1. Rising preference of minimally invasive surgeries
- 5.2.2. Risk of infection
5.3. Wound Closure Devices Market Opportunities
- 5.3.1. Integration of drug-eluting properties in wound closure devices

6. Wound Closure Devices Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Wound Closure Devices Market Assessment

7.1. By Product Type
- 7.1.1. Sealants and Adhesives
- 7.1.2. Staplers
- 7.1.3. Sutures
  - 7.1.3.1. Absorbable
  - 7.1.3.2. Non- absorbable
- 7.1.4. Hemostats
- 7.1.5. Others
7.2. By End-User
- 7.2.1. Hospitals
- 7.2.2. Clinics
- 7.2.3. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.1.2. Canada Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.1.3. Mexico Wound Closure Devices Market Size in USD Million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.2.2. Germany Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.2.3. United Kingdom Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.2.4. Italy Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.2.5. Spain Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.2.6. Rest of Europe Wound Closure Devices Market Size in USD Million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.3.2. Japan Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.3.3. India Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.3.4. Australia Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.3.5. South Korea Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Wound Closure Devices Market Size in USD Million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.4.2. Africa Wound Closure Devices Market Size in USD Million (2021-2030)
  - 7.3.4.3. South America Wound Closure Devices Market Size in USD Million (2021-2030)

8. Wound Closure Devices Market Company and Product Profiles

8.1. Medtronic
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. 3M
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Johnson & Johnson
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. B. Braun Melsungen AG
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Baxter
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Smith & Nephew
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Stryker
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Chemence Medical, Inc.
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Healthium Medtech
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Meril Life Sciences Pvt. Ltd.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Futura Surgicare Pvt Ltd.
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Advanced Medical Solutions Group plc.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Microcure (Suzhou) Medical Technology Co., Ltd.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. CooperSurgical Inc.
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Adhezion Biomedical
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. CENTENIAL SURGICAL SUTURE LTD
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Cardinal Health
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Dukal LLC
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. ORION SUTURES INDIA PVT LTD
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Lotus Surgicals
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy